Toxin公司于1984年成立,目的是向工業界和科學界提供的葡萄球菌毒素和抗毒素。此外,服務組件 公司成立是為了檢測食品和培養上清液中是否存在葡萄球菌毒素。該公司的創始人R.F.Reiser醫生和R.H.Deibel醫生是外派人員。 TS在各自領域的葡萄球菌研究公司成立時。Reiser博士在葡萄球菌腸桿菌的純化和鑒定方面有豐富的經驗。 是毒素休克綜合征毒素的。Deibel博士是威斯康星大學麥迪遜分校細菌系的主席,他也曾在那里做過。 食品中葡萄球菌和沙門氏菌生長及其毒素在動物模型中作用的研究。副總裁兼實驗室PaulBina于19歲加入Tox技術公司。 工作人員已增加到8名雇員,其中包括4名板凳科學家。目標是是為科學界提供盡可能高質量的毒素和相關產品。在服務方面,我們的政策是提供 對細菌毒素和霉菌毒素進行快速、靈敏和有效的檢測。
該公司的生產線已擴大到包括由鏈球菌和大腸桿菌生產的毒素。兔和羊制備的多克隆抗體可用于大多數 e毒素和小鼠單克隆抗體正在加入,因為他們可以使用。該公司的服務部門現在包括檢測額外的細菌毒素和霉菌毒素以及Perfor。 明血清中存在抗葡萄球菌和鏈球菌毒素的抗體。合同研究服務可用于毒素生產和毒素產品挑戰研究領域。這些研究 ES可以根據良好的實驗室實踐標準(GLPS)進行。
TOXINS AND DERIVATIVES 1, 2, 3, 4*
Highly Purified Staphylococcal Enterotoxins | |||||
Name | Catalog # | Sizes | Name | Catalog # | Sizes |
SEA | AT101 | 100 µg | SEE | ET404 | 100 µg |
SEB | BT202 | 1 mg | SEH | SEH-1 | 1 mg |
SEC1 | CT111 | 5 mg | SEJ | SEJ-1 | 5 mg |
SEC2 | CT222 | 10 mg | SEK | SEK-1 | 10 mg |
SEC3 | CT333 |
| TSST-1 | TT606 |
|
SED | DT303 |
| ExfoliativeToxin A | ST101 |
|
Endotoxin Minimized Enterotoxins Available Upon Request (< 1 EU/mg) Inquire |
Recombinant Staphylococcal Enterotoxins (rSEs) | |||||
rSEA | rAT101 |
| rSED | rDT303 |
|
rSEB | rBT202 |
| rSEE | rET404 |
|
rSEC-3 | rCT333 |
| rTSST-1 | rTT606 |
|
1Toxin grades are partially purified or highly purified. None are pure and all contain other
substances that co-purify and can be detected using improved or very sensitive methods.
2 These reagents are intended for laboratory and research purposes only. They are not
intended for human or veterinary drug use.
3 Minimum U.S. order $50.00, Min. International $250.00. Terms are net 30 days; U.S. dollars only.
4 The U.S. DOC requires Export Licenses for ALL Staph & Shiga Toxins.
Toxin Technology Assumes No Liability for the Use of these Products.
Highly Purified Staphylococcal Enterotoxins Endotoxin Reduced < 5 EU per mg. | |||||
Name | Catalog # |
|
|
|
|
SEA | AT101red |
| SEE | ET404red |
|
SEB | BT202red |
| SEH | SEH-1red |
|
SEC1 | CT111red |
| SEJ | SEJ-1red |
|
SEC2 | CT222red |
| SEK | SEK-1red |
|
SEC3 | CT333red |
| TSST-1 | TT606red |
|
SED | DT303red |
| Exfoliative Toxin A | ST101red |
|
Further Endotoxin Reduction Available Upon Request (< 1 EU/mg) Inquire |
Recombinant Staphylococcal Enterotoxins (rSEs) | |||||
rSEA | rAT101red |
| rSED | rDT303red |
|
rSEB | rBT202red |
| rSEE | rET404red |
|
rSEC-3 | rCT333red |
| rTSST-1 | rTT606red |
|
Staphylococcal Enterotoxin Toxoids (SE-X) | |||||
SEA-X | AT101-X |
| SEB-X | BT202-X |
|
Other Toxoids Can Be Prepared Upon Request |
Partially Purified Staphylococcal Enterotoxins | |||||||
Name | Catalog # |
| Name | Catalog # |
| ||
SEA | AP101 |
| SED | DP303 |
| ||
SEB | BP202 |
| SEE | EP404 |
| ||
SEC’s | CP1, 2, 3 |
| TSST-1 | TP606 |
| ||
Other Partially Purified Toxins can be Prepared on Request. | |||||||
Biotinylated Staphylococcal Enterotoxins | |||||||
Name | Catalog # | Name | Catalog # | ||||
SEA | AT101-B | SEE | ET404-B | ||||
SEB | BT202-B | TSST-1 | TT606-B | ||||
SEC’s | CT1, 2, 3-B | ExfoliativeToxin A | ST101-B | ||||
SED | DT303-B |
|
| ||||
Other Products Can be Biotinylated on Request | |||||||
Staphylococcal Thermonuclease | |||||||
Quantity | Catalog #’s | 250 µ-molar units | SN250 | ||||
5000 µ-molar units | SN5000 | 500 µ-molar units | SN500 | ||||
Staphylococcal Hemolysins | |||||||
Description | Catalog # | Description | |||||
Alpha Hemolysin - partially purified | HP101 | BHP1 | Beta Hemolysin - partially purified | ||||
Alpha Hemolysin - highly purified | HT101 | BHT1 | Beta Hemolysin - highly purified | ||||
Staphylococcal Peptidoglycan | |||||||
Description | Catalog # |
| |||||
Staphylococcal peptidoglycan | STPG1 |
|
ANTISERA
RABBIT
Staphylococcal Antitoxins | |||||||||
Name | Catalog # | Name | Catalog # | ||||||
Anti - SEA | AS101 | Anti - SED | DS303 | ||||||
Anti - SEB | BS202 | Anti - SEE | ES404 | ||||||
Anti - SEC1 | CS111 | Anti - SEH | SEHS - 1 | ||||||
Anti - SEC2 | CS222 | Anti - TSST-1 | TS606 | ||||||
Anti - SEC3 | CS333 | Anti - DNase | NS101 | ||||||
Affinity Purified | IgG IgG HRPO Conj. IgG Biotinylated |
| |||||||
Name | Catalog # IgG |
| Catalog # HRPO |
| Catalog # Biotinylated |
|
| ||
Anti - SEA | LAI101 |
| LAC101 |
| BAC101 |
|
| ||
Anti - SEB | LBI202 |
| LBC202 |
| BBC202 |
|
| ||
Anti - SEC | LCI111 |
| LCC111 |
| BCC111 |
|
| ||
Anti - SED | LDI303 |
| LDC303 |
| BDC303 |
|
| ||
Anti - SEE | LEI404 |
| LEC404 |
| BEC404 |
|
| ||
Anti - SEH | LSEHI-1 |
| LSEHC-1 |
| BHC-1 |
|
| ||
Anti - TSST-1 | LTI101 |
| LTC101 |
| BTC101 |
|
| ||
Anti - DNase | LNI101 |
| LNC101 |
| BNC101 |
|
|
Normal Rabbit Serum Tested to be Free of Antibodies to SEA-E & TSST-1 | ||||
Cat. # NRS-5 | 5 mL |
| Cat. # NRS-10 | 10 mL |
ANTISERA
SHEEP
Staphylococcal Antitoxins | ||||||||
Name | Catalog # | Name | Catalog # | |||||
Anti - SEA | SAS101 | Anti - SEE | SES404 | |||||
Anti - SEB | SBS202 | Anti - TSST-1 | STS606 | |||||
Anti - SEC1 | SCS111 | Anti - Exfoliative toxin A | SSS101 | |||||
Anti - SEC2 | SCS222 | Anti - Alpha-hemolysin | SHS101 | |||||
Anti - SEC3 | SCS333 | Anti - DNase | SNS101 | |||||
Anti - SED | SDS303 |
|
| |||||
| Affinity Purified | IgG | IgG HRPO Conj. | IgG Biotinylated | ||||
| Name | Cat. # |
| Cat. # |
| Cat. # |
| |
| Anti - SEA | SLAI101 |
| SLAC101 |
| SBAC101 |
| |
| Anti - SEB | SLBI202 |
| SLBC202 |
| SBBC202 |
| |
| Anti - SEC | SLCI111 |
| SLCC111 |
| SBCC111 |
| |
| Anti - SED | SLDI303 |
| SLDC303 |
| SBDC303 |
| |
| Anti - SEE | SLEI404 |
| SLEC404 |
| SBEC404 |
| |
| Anti - TSST-1 | SLTI101 |
| SLTC101 |
| SBTC101 |
| |
| Anti - ET-A | SLSI505 |
| SLSC505 |
| SBSC505 |
| |
| Anti - DNase | SLNI101 |
| SLNC101 |
| SBNC101 |
| |
| Anti- α-Hemolysin | SLHI101 |
| SLHC101 |
| SBHC |
|
Murine Monoclonal Antibodies to the Staph Toxins
MA108 Anti-SEA, γ2b, Xreacts with SEE. Overlaps Zn++ MHC binding site,
requires Zn++ for binding. (Kappler & Marrack) 1mg
MBI202 Prepared against Staphylococcal Enterotoxin B 1mg
IgG; Reactivity: Anti-SEB & SEC.
MB344 Anti-SEB, γ1, 6.0 nM, Not overlapping with the SEB MHC or TCR
interaction site (Kappler & Marrack) 1mg
MB327 Anti-SEB, γ2b, 95 nM, Not overlapping with the SEB MHC or TCR
interaction site (Kappler & Marrack) 1mg
MB2B33 Anti-SEB, γ1, 5.2 nM, Overlaps with the SEB MHC interaction site.
(Kappler & Marrack) 1mg
MB87 Anti-SEB, γ1, 9.3 nM, Overlaps with the SEB TCR interaction site.
(Kappler & Marrack) 1mg
MC165 Anti-SEC, γ1, Reacts with SEC1 (1.5nM) > SEC3 (20nM) > SEC2 (75nM)
(Kappler & Marrack) 1mg
MCTS-1 Prepared against Toxic Shock Syndrome Toxin-1 1mg
(Formerly Cat. # TS-2) IgG; Reactivity: Anti-TSST-1.
Streptococcal Reagents
Streptococcal pyrogenic exotoxins ( SPE ), Native | SPE, Recombinant (rSPE) | ||
Name | Catalog # | rSPE-A (Allele-1) | rPTA111 |
SPE-B | PTB222 | rSPE-C | rPTC333 |
Streptococcal antitoxins | |||||||
Name | Catalog # |
| Source | ||||
Anti-SPE-A | PSA111 |
| sheep | ||||
Anti-SPE-A | RPSA1 |
| rabbit | ||||
Anti-SPE-B | PSB222 |
| rabbit | ||||
Anti-SPE-C | PSC333 |
| rabbit | ||||
Affinity Purified | IgG Rabbit | IgG HRPO Conjugate | |||||
Name | Catalog # |
| Catalog # |
| |||
Anti - SPE-A
|
PAI111 |
|
PAC111 |
| |||
Anti - SPE-B |
PBI222 |
|
PBC222 |
| |||
Anti - SPE-C |
PCI333 |
|
PCC333 |
|
Streptococcal Peptidoglycan | ||
Description | Catalog # | Quantity |
Streptococcal peptidoglycan | SRPG1 | 10 mg |
Shigatoxin (Verotoxin) Reagents
Monoclonal Antibodies (Murine)
STX1-9C9 1mg
Reference: Padhye, V.V. et al. 1989. J. Med. Microbiol. 30:219-226.
Reported Specificity: VT-1; A,A1,B, Neutralizing; VT-2; A,A1,
Non-neutralizing. Isotype, IgG1
STX1-3C10 1mg
Reference: Same as above.
Reported Specificity: Same as above. Isotype, IgG1
STX1-10D11 1mg
Reference: Same as above.
Reported Specificity: VT-1; A,A1,B, Neutralizing; VT-2; A,A1,B,
Non-neutralizing. Isotype, IgG2b
STX2-BB12 1mg
Reference: Pouch Downes, F. et al. 1988. Infection & Immunity. 56:1926-
1933.
Reported Specificity: VT-2; B, Neutralizing. The clone was received as
BB-12; some researchers report that it does not react
the same as the original “BB12” MAb. Isotype, IgG1
STX1-13C4 1mg
Reference: Strockbine N.A. et al 1985. Infection & Immunity. 50:695-700.
Reported Specificity: VT-1; B, Neutralizing.
Note: This MAb can be purchased and used for research purposes only, it is
Not to be used for any commercial purposes and is limited by the
Licensee to a maximum of 5mg per purchase. Isotype, IgG1 κ
STX2-11E10 1mg
Reference: Perera, L.F. et al. 1988. J. Clin. Microbiol. 26:2127-2131.
Reported Specificity: VT-2, Neutralizing(+/-)
Note: The same use conditions as STX1-13C4 apply to this MAb
Isotype, IgG1 κ
Shigatoxin Reagents, Continued
Pooled Monoclonal Antibodies
STXPI-1 1mg Pool of MAb 9C9, 3C10, 10D11 & BB12
STXPC-1 0.5mL Pooled MAb IgG-HRPO Conjugate
BSTXPC-1 0.5mL Pooled MAb IgG-Biotin Conjugate
Shigatoxins (STX, Verotoxins, VT)
STX-1 (Formerly, SLT-1) Partially Purified Shigatoxin-1* 0.5 mg
STX-2 (Formerly, SLT-2) Partially Purified Shigatoxin-2* 0.5 mg
* At least 10 7 Verocytotoxic units/mg.
Ricin Reagents
RCAX-1 Ricin (RCA 60) Toxoid 1 mg
LRCAI-1 Anti-Ricin, Polyclonal Rabbit IgG 1 mg
LRCAC-1 Anti-Ricin IgG-HRPO 0.5 mL
Abrin Reagents
ABR-1 Abrin Toxin (Mixed Isomers) 1 mg
ABRX-1 Abrin Toxoid 1 mg
AABR-1 Anti-Abrin (Inquire)
Listeria Monocytogenes typing antibodies
General technical information
These antibody reagents have been developed in rabbits and are specific for
the somatic and flagellar antigens of Listeria monocytogenes. They may be
used to identify and characterize different serotypes of L. monocytogenes.
The reagents are sold in a lyophilized form and are under vacuum. In this
evacuated, freeze-dried form, the antibodies are stable for several years when
stored at - 20 0C or lower.
To rehydrate the antibody reagents, it is recommended to add an equivalent
volume of deionized water (usually l ml) to the vial, then aliquot the content to
convenient working volumes and freeze any of the aliquots which will not be
used within several days. The shelf life of the rehydrated reagent is
approximay one week at 4 0C and one year at - 20 0C.
To prepare an aliquot of rehydrated reagent for use in the FDA-BAM serological
typing procedure, dilute the reagent to the recommended dilution with PBS-
Tween (0.01 M phosphate, 0.9 % NaCl, 0.05 % Tween-20, pH to 7.4) The diluted
working reagent should be used within 8 hours.
Listeria monocytogenes serotyping reagents:
Somatic Groups
Serotype (O - antigens)
anti - O1a (1) cat. no. LMO1
anti - O1a (1,2) cat. no. LMO12
anti - O3a (4) cat. no. LMO3
anti - O4a (7,9) cat. no. LMO4A
anti - O4b (6) cat. no. LMO4B6
anti - O4b (5,6) cat. no. LMO4B56
anti - O4d (8) cat. no. LMO4D
Flagellar Groups
Flagellar antigen
anti - HA cat. no. LMHA
anti - HC cat. no. LMHC
anti - HD cat. no. LMHD
Sold in Individual 1 mL Units or in Set of 1 mL each.
The Listeria monocytogenes serotyping reagents are absorbed,
hyper-immune rabbit serum products. These products are used
in the FDA-BAM serotyping procedure
TEST SERVICES - DESCRIPTION AND PRICES
Bacterial Toxins Mycotoxins
- Total aflatoxins, B’s and G’s - Aflatoxin M1 - Zearalenone - Vomitoxin - T-2 toxin - Fumonisin - Ochratoxin A - Sterigmatocystin - Patulin
Serotyping
- Salmonella - Listeria - E. coli
Staphylococcal Exoproteins -Toxic Shock Syndrome Toxins - Serum sample (TSST-1 Titer)* - Paired sera, acute and convalescent (TSST-1Titer)* - isolate (toxin panel) A-E & TSST-1 - DNase (ELISA) - Coagulase - Mitogenicity (TC) - Exfoliative Toxin A (ELISA) - IgE Titer (SEs/TSST-1)* -IgG Titer (SEA,B,Cs,D,E&TSST-1)*
Toxicology In vivo acute toxicology (mouse)
In vitro cytotoxicity with various cell lines
*Serologies are for investigative purposes only, not for human diagnostic use. TOX TECH is NOT a CLIA LICENSED FACILITY.
|
Staphylococcal enterotoxins
- FDA-BAM Screen (no typing)
- Confirmation (ELISA-typing) - Confirmation & Quantitation
- Confirmation (Microslide)
Escherichia coli toxicology/pathology
- verotoxins (shiga-like toxins)
- ELISA (no typing)
- ELISA (typing)
- Tissue culture (TC)
- Labile enterotoxin (RPLA) - invasiveness / adherence (TC)
Streptococcal Toxins
- pyrotoxins A,B, and C (ELISA)
Bacillus cereus toxins
- diarrheal enterotoxin (ELISA) - emetic enterotoxin (TC)
Inquire
Clostridial toxins
- perfringens alpha toxin (enzyme)
- perfringens enterotoxin (RPLA)
- botulinal toxin screen (FDA)
- botulinal toxin typing (FDA)
Miscellaneous Toxins
Paralytic shellfish toxin, i.e.,
Saxitoxin (mouse)
Saxitoxin (ELISA)
Endotoxin
-Qualitative (Limulus)
-Quantitative (Limulus)
References
Staphylococcal Enterotoxins:
Press, London. (SEA-E)
Foods. (1982) Appl. Environ. Microbiol. 44:1349-55.
Shock-Syndrome Staphylococcus Aureus Isolates. (1981) Lancet. 1017-21.
5. Munson, S.H. et al. Identification and Characterization of Staphylococcal Enterotoxin Types G and
I from Staphylococcus aureus. (1998) Infection and Immunity. 66:3337-48.
6. Su, Y.-C. and A.C.L. Wong. Identification and Purification of a New Staphylococcal Enterotoxin,
H. (1995) Appl. Environ. Microbiol. 61:1438-43.
enterotoxin determinant (SEJ). (1998) FEMS Microbiol. Lett. 168(2):227-33.
8. Owen, P.M. et al. Biochemical and Biological Properties of Staphylococcal Enterotoxin K. (2001)
Infection & Immunity. 69:360-366.
9. SEL, Dr. Pat Schlievert’s Group (Unpublished)
10. Jarraud, S. et al. egc, A Highly Preventive Operon of Enterotoxin Gene, Forms a Putative Nursery
of Superantigens in Staphylococcus aureus. 2001. J. Immunology. 166:669-677. An Erratum to
this article was published in J. Immunology 166:4259. (SEM, N & O)
11. Reiser, R.F. et al. Purification and Some Physicochemical Properties of Toxic-Shock-Toxin. (1983)
Biochemistry. 22: 3907-12. (TSST-1)
12. Reiser, R.F. et al. Production of Toxic Shock Syndrome Toxin-1 by Staphylococcus aureus Restricted to Endogenous Air in Tampons. (1987) J. Clin. Microbiol. 25:1450-52.
13. Schlievert, P.M. et al. Identification an Characterization of an Exotoxin from Staphylococcus aureus Associated with Toxic-Shock Syndrome. (1981) Infect. Dis.143:509-516. [This the first reference to Pyrogenic Exotoxin C. (PEC, aka SEF & TSST-1)]
14. Schlievert, P.M. & J.A. Kelly. Staphylococcal Pyrogenic Exotoxin C: Further Characterization.
(1982) Ann. Intern. Med. 96(6 pt. 2):982-986
Staphylococcal Enterotoxins as Superantigens:
1. Taranta, A. Lymphocyte Mitogens of Staphylococcal Origin. (1974) Ann. N.Y. Acad. Sci.
236:362-375.
2. White, J. et al. The Vß-Specific Superantigen Enterotoxin B: Stimulation of Mature T Cells and
Clonal Deletion in Neonatal Mice. (1989) Cell. 56:27-35. [Note: This is the 1st paper to use the term
Superantigen!]
3. Marrack, P. & J. Kappler. The Staphylococcal Enterotoxins and Their Relatives. (1990)
Science. 248705-711.
4. Johnson H. et al. Superantigens in Human Disease. (1992) Scientific American. April: 92-101.
5. Hudson, K.R. et al. Two Adjacent Residues in Staphylococcal Enterotoxins A and E
Determine T Cell Receptor Vß Specificity. (1993) J. Exp. Med. 177:175-184.
6. Kotb, M. Bacterial Pyrogenic Exotoxins as Superantigens. (1995) Clin. Microbiol. Rev.
8:411-426.
7. Proft,T. & J. Fraser. Superantigens: Just Like Peptides Only Different. (1998) J. Clin. Immunol.
Bernal, A. et al. 19:149-157.
8. Al-Daccak, R. et al. Staphylococcal Enterotoxin D Is a Promiscuous Superantigen Offering
Multiple Modes of Interactions with the MHC Class II Receptors. (1998) J. Immunology.
160: 225-232.
9. Jarraud, S. et al. egc, A Highly Prevalent of Enterotoxin Gene, Forms a Putative Nursery of
Superantigens in Staphylococcus aureus. (2001) J. Immunology. 166: 669-677.
10. LeClaire, R.D. and S. Bavari. Human Antibodies to Bacterial Superantigens and Their Ability
To Inhibit T-Cell Activation and Lethality. (2001) Antimicrobial Agents and Chemotherapy.
45; 460-463.
Streptococcal Pyrogenic Exotoxins as Superantigens
Requirement for MHC Class II Molecules on Accessory Cells and Identification of Vβ Elements in
T-Cell Receptor of Toxin-reactive T-Cells. (1990) J. Immunol. 145:3170-3176.
2. Li, P-L. et al. The Superantigen Streptococcal Pyrogenic Exotoxin C (SPE-C) Exhibits a Novel
Mode of Action. (1997) J. Exp. Med. 186:375-383.
3. McCormick, J.K. et al. Functional Characterization of Streptococcal Pyrogenic Exotoxin J,
a Novel Superantigen. (2001) Infection and Immunity 69:1381-1388.
Shiga Toxin & Monoclonal Antibodies to SLT-1 & 2
1. Strockbine, N.A. et al. Characterization of Monoclonal Antibodies against Shiga-Like Toxin
from Escherichia coli. 1985. Infection and Immunity. 50:695-700.
2. Pouch Downes, F. et al. Affinity Purification and Characterization of Shiga-Like Toxin II and
Production of toxin-Specific Monoclonal Antibodies. Infection and Immunity. 56:1926-1933.
3. Perera, L.P. et al. Isolation and Characterization of Monoclonal Antibodies to Shiga-Like
Toxin II of Enterohemorrhagic Escherichia coli and Use of Monoclonal Antibodies in a
Colony Enzyme-Linked Immunosorbent Assay. 1988. J. Clin. Microbiol. 26:2127-213
4. Padhye, V.V. et al. Production and Characterization of Monoclonal Antibodies to Verotoxins
1 and 2 from Escherichia coli of Serotype O 157:H7. 1989. J. Med. Micro. 30:219-226.
Bioterrorism & Bacterial Toxins
1. Christopher, G.W., et al. Biological Warfare—A Historical Perspective. 1997.
JAMA. 278:412-417.
2. Franz, D.R., et al. Clinical Recognition and Management of Patients Exposed to Biological
Agents. 1997. JAMA. 278:399-411.
3. Schmitt, C.K. et al. Bacterial Toxins: Friends or Foes? 1999. Emerging Infectious Diseases.
5:224-234.
4. Greenfield, R.A., et al. Microbiological, Biological, and Chemical Weapons of Warfare and
Terrorism. 2002. Am. J. Med. Sci. 323:326-340.
上海起發實驗試劑有限公司是實驗試劑一站式采購服務商
1:強大的進口輻射能力,血清、抗體、耗材、大部分限制進口品等。
2:產品種類齊全,經營超過700多個品牌,基本涵蓋所有生物實驗試劑耗材。
3:提供加急服務,貨品一般1-2周到貨。
4:富有競爭力的價格優勢,絕大部分價格有優勢。
5:多年積累良好的信譽,大部分客戶提供貨到付款服務??蛻舭ㄇ迦A、北大、交大、復旦、中山等100多所高校,ROCHE,阿斯利康、國藥、fisher等藥企。
6:我們還是Santa,Advanced Biotechnologies Inc,Athens Research & Technology,bangs,BBInternational,crystalchem,dianova,FD Neurotechnologies,Inc. FormuMax Scientific,Inc, Genebridege, Glycotope Biotechnology GmbH; iduron,Innovative Research of America, Ludger, neuroprobe,omicronbio, Polysciences,prospecbi, QA-BIO,quickzyme,RESEARCH DIETS,INC,sterlitech;sysy,TriLink BioTechnologies,Inc;worthington-biochem,zyagen等幾十家國外公司授權代理。
7:我們還是invitrogen,qiagen,MiraiBioam,sigma;neb,roche,merck, rnd,BD, GE,pierce,BioLegend等*批發,歡迎合作。